Root Maya Antionette, Pavlich Carolyn Maria Ibrahim, Sochet Anthony Alexander, Roberts Alexa Rae, Russi Brett Walter
Lincoln Memorial University-DeBusk College of Osteopathic Medicine, Harrogate, TN, USA.
Division of Pediatric Critical Care Medicine, Johns Hopkins All Children's Hospital, St. Petersburg, FL, USA.
Pediatr Gastroenterol Hepatol Nutr. 2024 Nov;27(6):364-371. doi: 10.5223/pghn.2024.27.6.364. Epub 2024 Nov 5.
The practice of withholding oral nutrition for children hospitalized for critical asthma receiving continuous albuterol is not evidence based. We sought to characterize oral nutrition practices in this population and estimate the frequency of aspiration-related respiratory failure.
We performed a single-center retrospective, matched cohort study of children 3-17 years of age admitted to a pediatric intensive care unit from Oct 2020 to May 2023 for critical asthma receiving continuous albuterol. Cases provided oral nutrition were matched 1:2 to controls withheld nutrition by age and National Heart Lung and Blood Institute asthma severity classification. The primary outcome was aspiration-related respiratory failure defined as any respiratory support escalation following observed aspiration. Descriptive data included demographics, anthropometrics, pediatric asthma severity scores, adjunct asthma interventions, continuous albuterol duration, mortality, and length of stay.
Of 36 cases and 72 matched controls, the mean age was 9.1±3.9 years and 66.7% had moderate-severe persistent asthma. Cases and controls had comparable anthropometrics and admission pediatric asthma severity scores. No aspiration-related respiratory failure events were observed even among those receiving nutrition concurrent to noninvasive ventilation. Compared to controls, cases experienced a longer continuous albuterol duration (median: 1.1 [interquartile range: 0.7-1.8] versus 0.7 [interquartile range: 0.3-1.3] days, <0.001). No differences in length of stay, adjunct interventions, endotracheal intubation rates, and mortality were observed between cases and controls.
For children hospitalized for critical asthma, oral nutrition during continuous nebulized albuterol appeared well tolerated. While prospective validation is required, the practice of withholding oral nutrition for continuous albuterol administration may be unwarranted.
对于因重症哮喘住院且接受持续沙丁胺醇治疗的儿童,停止口服营养支持的做法并无循证依据。我们试图描述该人群的口服营养支持情况,并估计与误吸相关的呼吸衰竭发生率。
我们进行了一项单中心回顾性匹配队列研究,研究对象为2020年10月至2023年5月因重症哮喘入住儿科重症监护病房且接受持续沙丁胺醇治疗的3至17岁儿童。提供口服营养支持的病例按年龄和美国国立心肺血液研究所哮喘严重程度分级与停止营养支持的对照进行1:2匹配。主要结局是与误吸相关的呼吸衰竭,定义为观察到误吸后任何呼吸支持的升级。描述性数据包括人口统计学、人体测量学、儿童哮喘严重程度评分、辅助哮喘干预措施、持续沙丁胺醇治疗时间、死亡率和住院时间。
在36例病例和72例匹配对照中,平均年龄为9.1±3.9岁,66.7%患有中度至重度持续性哮喘。病例组和对照组的人体测量学和入院时儿童哮喘严重程度评分相当。即使在接受无创通气同时接受营养支持的患者中,也未观察到与误吸相关的呼吸衰竭事件。与对照组相比,病例组的持续沙丁胺醇治疗时间更长(中位数:1.1[四分位间距:0.7 - 1.8]天对0.7[四分位间距:0.3 - 1.3]天,<0.001)。病例组和对照组在住院时间、辅助干预措施、气管插管率和死亡率方面未观察到差异。
对于因重症哮喘住院的儿童,持续雾化沙丁胺醇治疗期间的口服营养支持似乎耐受性良好。虽然需要前瞻性验证,但因持续使用沙丁胺醇而停止口服营养支持的做法可能没有必要。